Abstract
Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan may result in hemorrhagic tumor necrosis with acute orbital and intracranial inflammation.
MeSH terms
-
Acute Disease
-
Antibodies, Monoclonal / adverse effects*
-
Antigens, CD20
-
Encephalitis / diagnosis
-
Encephalitis / etiology*
-
Humans
-
Lymphoma, Large B-Cell, Diffuse / pathology
-
Lymphoma, Large B-Cell, Diffuse / radiotherapy*
-
Magnetic Resonance Imaging
-
Male
-
Middle Aged
-
Necrosis
-
Orbital Cellulitis / diagnosis
-
Orbital Cellulitis / etiology*
-
Orbital Neoplasms / pathology
-
Orbital Neoplasms / radiotherapy*
-
Radioimmunotherapy / adverse effects*
-
Yttrium Radioisotopes
Substances
-
Antibodies, Monoclonal
-
Antigens, CD20
-
Yttrium Radioisotopes
-
ibritumomab tiuxetan